Fda Reconsiders
Sort by
16 items
-
Politics - The Hill
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...7 hours ago -
Top stories - NBC News
Compounding pharmacies can resume making tirzepatide as FDA reconsiders shortage
The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of tirzepatide as it reconsiders whether the drug is in shortage.8 hours ago -
Lifestyle - The New York Times
Reconsidering the Hollywood Reporter’s A-List of Influencers
A social media post about the Hollywood Reporter’s “A-List” of influencers inspired quite a few jokes online. But part of that was a misunderstanding.2 days ago